Adage Capital Partners Gp, L.L.C. Kezar Life Sciences, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $2.24 Million - $3.01 Million	-280,000 Reduced 58.33%	200,000 $1.72 Million
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $6.34 Million - $23.7 Million	-1,384,853 Reduced 74.26%	480,000 $3.97 Million
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $2.36 Million - $3.52 Million	-191,819 Reduced 9.33%	1,864,853 $31 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $15.3 Million - $34.4 Million	2,056,672 New	2,056,672 $34.4 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.